Clinical Learning PlatformIDHub

Resistance by Default

Clinical Vignette

A 58-year-old man with Child-Pugh B alcoholic cirrhosis and type 2 diabetes is admitted with a 2-day history of fever, rigors, and progressive confusion. He has not been hospitalized in over 8 months. He takes furosemide, spironolactone, and lactulose at home. He denies recent antibiotic use, foreign travel, or new dietary changes.

On examination he is febrile to 38.7°C with a heart rate of 108 beats per minute and blood pressure of 102/68 mmHg. He is jaundiced with scleral icterus, has mild asterixis, and is oriented only to person. Abdominal examination reveals a distended abdomen with shifting dullness and mild diffuse tenderness without peritoneal signs. Spider angiomata are present on the chest. There is 2+ pitting edema of the lower extremities bilaterally. No focal skin or soft tissue findings are identified. Cardiopulmonary examination is unremarkable.

Laboratory data show white blood cell count 14,800/μL with 82% neutrophils, hemoglobin 10.2 g/dL, and platelets 88,000/μL. Comprehensive metabolic panel shows total bilirubin 4.2 mg/dL, ALT 58 U/L, AST 74 U/L, alkaline phosphatase 186 U/L, creatinine 1.6 mg/dL, and albumin 2.8 g/dL. INR is 1.9. Urinalysis is unremarkable. Diagnostic paracentesis is performed and shows 180 white blood cells/mm³ with 52% neutrophils.

Two sets of blood cultures are drawn from separate peripheral sites. Both become positive at 18 hours with gram-positive cocci in pairs and short chains. The organism is identified as Enterococcus gallinarum by MALDI-TOF mass spectrometry. The automated susceptibility system reports the following: ampicillin susceptible (MIC 0.5 μg/mL), vancomycin resistant (MIC 8 μg/mL), teicoplanin susceptible (MIC 0.5 μg/mL), linezolid susceptible, and daptomycin susceptible. The laboratory automatically flags the result as "vancomycin-resistant enterococcus (VRE)" and notifies the infection control team. The covering team calls you, the infectious diseases fellow on call, asking whether to start linezolid and initiate VRE contact precautions.

Question 1

Which of the following best describes the correct interpretation of the vancomycin resistance reported for this organism?

Select one option to submit your answer and view live poll results.


Question 2

Which of the following is the most appropriate antibiotic treatment for this patient's Enterococcus gallinarum bacteremia?

Select one option to submit your answer and view live poll results.


Question 3

Regarding infection control, which of the following is the most appropriate response to this organism?

Select one option to submit your answer and view live poll results.


Answer the question above to reveal the rationale.
Answer the question above to reveal the rationale.

References

Courvalin P. Vancomycin resistance in gram-positive cocci. Clinical Infectious Diseases. 2006;42(Suppl 1):S25-S34.

DOI: 10.1086/491711

Uttley AH, George RC, Davies J, et al. High-level vancomycin-resistant enterococci causing hospital infections. Epidemiology and Infection. 1989;103(1):173-181.

DOI: 10.1017/s0950268800030478

Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nature Reviews Microbiology. 2012;10(4):266-278.

DOI: 10.1038/nrmicro2761

Recommendations for preventing the spread of vancomycin resistance: recommendations of the Hospital Infection Control Practices Advisory Committee (HICPAC). Infection Control and Hospital Epidemiology. 1995;16(2):105-113.

DOI: 10.1086/647066